Rank | Gene Set | Z-score |
---|---|---|
1 | exogenous drug catabolic process (GO:0042738) | 8.72722021 |
2 | epoxygenase P450 pathway (GO:0019373) | 8.03841361 |
3 | omega-hydroxylase P450 pathway (GO:0097267) | 7.91732134 |
4 | L-phenylalanine catabolic process (GO:0006559) | 7.30402088 |
5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.30402088 |
6 | L-phenylalanine metabolic process (GO:0006558) | 7.07222891 |
7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.07222891 |
8 | aromatic amino acid family catabolic process (GO:0009074) | 6.64671493 |
9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.57719233 |
10 | indole-containing compound catabolic process (GO:0042436) | 6.11217229 |
11 | indolalkylamine catabolic process (GO:0046218) | 6.11217229 |
12 | tryptophan catabolic process (GO:0006569) | 6.11217229 |
13 | negative regulation of fibrinolysis (GO:0051918) | 6.02774850 |
14 | high-density lipoprotein particle remodeling (GO:0034375) | 6.00593874 |
15 | kynurenine metabolic process (GO:0070189) | 5.94613378 |
16 | drug metabolic process (GO:0017144) | 5.83350831 |
17 | urea cycle (GO:0000050) | 5.76115218 |
18 | urea metabolic process (GO:0019627) | 5.76115218 |
19 | bile acid biosynthetic process (GO:0006699) | 5.73089847 |
20 | regulation of fibrinolysis (GO:0051917) | 5.71933406 |
21 | tryptophan metabolic process (GO:0006568) | 5.71142457 |
22 | regulation of cholesterol esterification (GO:0010872) | 5.69461578 |
23 | oxidative demethylation (GO:0070989) | 5.68931713 |
24 | regulation of protein activation cascade (GO:2000257) | 5.65241273 |
25 | glyoxylate metabolic process (GO:0046487) | 5.56382131 |
26 | complement activation, alternative pathway (GO:0006957) | 5.55371201 |
27 | protein carboxylation (GO:0018214) | 5.52255399 |
28 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.52255399 |
29 | alpha-linolenic acid metabolic process (GO:0036109) | 5.36590647 |
30 | nitrogen cycle metabolic process (GO:0071941) | 5.28243742 |
31 | phospholipid efflux (GO:0033700) | 5.20875272 |
32 | regulation of complement activation (GO:0030449) | 5.20123626 |
33 | protein-lipid complex remodeling (GO:0034368) | 5.17630325 |
34 | macromolecular complex remodeling (GO:0034367) | 5.17630325 |
35 | plasma lipoprotein particle remodeling (GO:0034369) | 5.17630325 |
36 | reverse cholesterol transport (GO:0043691) | 5.12868447 |
37 | regulation of triglyceride catabolic process (GO:0010896) | 5.08003820 |
38 | phenylpropanoid metabolic process (GO:0009698) | 5.03874571 |
39 | cysteine metabolic process (GO:0006534) | 5.01716850 |
40 | sulfur amino acid catabolic process (GO:0000098) | 5.01539247 |
41 | negative regulation of sterol transport (GO:0032372) | 4.92850320 |
42 | negative regulation of cholesterol transport (GO:0032375) | 4.92850320 |
43 | serine family amino acid catabolic process (GO:0009071) | 4.92414494 |
44 | bile acid metabolic process (GO:0008206) | 4.90294825 |
45 | aromatic amino acid family metabolic process (GO:0009072) | 4.83345012 |
46 | negative regulation of blood coagulation (GO:0030195) | 4.82583753 |
47 | negative regulation of hemostasis (GO:1900047) | 4.82583753 |
48 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.82169397 |
49 | ethanol metabolic process (GO:0006067) | 4.81690042 |
50 | plasma lipoprotein particle clearance (GO:0034381) | 4.72014231 |
51 | tyrosine metabolic process (GO:0006570) | 4.63385859 |
52 | cholesterol efflux (GO:0033344) | 4.59740859 |
53 | acylglycerol homeostasis (GO:0055090) | 4.59734305 |
54 | triglyceride homeostasis (GO:0070328) | 4.59734305 |
55 | acute-phase response (GO:0006953) | 4.54986540 |
56 | * regulation of humoral immune response (GO:0002920) | 4.48104175 |
57 | homocysteine metabolic process (GO:0050667) | 4.46936646 |
58 | alpha-amino acid catabolic process (GO:1901606) | 4.46017776 |
59 | plasma lipoprotein particle assembly (GO:0034377) | 4.45034496 |
60 | S-adenosylmethionine metabolic process (GO:0046500) | 4.43630655 |
61 | negative regulation of coagulation (GO:0050819) | 4.39293018 |
62 | negative regulation of wound healing (GO:0061045) | 4.37028546 |
63 | amino-acid betaine metabolic process (GO:0006577) | 4.36083036 |
64 | lysine metabolic process (GO:0006553) | 4.35479516 |
65 | lysine catabolic process (GO:0006554) | 4.35479516 |
66 | indolalkylamine metabolic process (GO:0006586) | 4.28642588 |
67 | fibrinolysis (GO:0042730) | 4.27455981 |
68 | benzene-containing compound metabolic process (GO:0042537) | 4.26848751 |
69 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.24681929 |
70 | cellular biogenic amine catabolic process (GO:0042402) | 4.21166158 |
71 | amine catabolic process (GO:0009310) | 4.21166158 |
72 | coenzyme catabolic process (GO:0009109) | 4.19016773 |
73 | bile acid and bile salt transport (GO:0015721) | 4.18833863 |
74 | negative regulation of lipase activity (GO:0060192) | 4.13898239 |
75 | glycine metabolic process (GO:0006544) | 4.13509626 |
76 | low-density lipoprotein particle remodeling (GO:0034374) | 4.11787499 |
77 | positive regulation of hemostasis (GO:1900048) | 4.08143669 |
78 | positive regulation of blood coagulation (GO:0030194) | 4.08143669 |
79 | cellular amino acid catabolic process (GO:0009063) | 4.07084068 |
80 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.06417821 |
81 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.06417821 |
82 | cellular ketone body metabolic process (GO:0046950) | 4.06132100 |
83 | alkaloid metabolic process (GO:0009820) | 4.04722701 |
84 | glutamate metabolic process (GO:0006536) | 4.04134156 |
85 | cellular glucuronidation (GO:0052695) | 4.03177240 |
86 | opsonization (GO:0008228) | 4.03038716 |
87 | imidazole-containing compound metabolic process (GO:0052803) | 4.01633915 |
88 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.01288019 |
89 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.01288019 |
90 | arginine metabolic process (GO:0006525) | 4.01212767 |
91 | blood coagulation, intrinsic pathway (GO:0007597) | 4.01150504 |
92 | protein-lipid complex assembly (GO:0065005) | 3.98403573 |
93 | drug catabolic process (GO:0042737) | 3.97704781 |
94 | serine family amino acid metabolic process (GO:0009069) | 3.97087350 |
95 | positive regulation of lipid catabolic process (GO:0050996) | 3.96545448 |
96 | hormone catabolic process (GO:0042447) | 3.94991058 |
97 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.94732495 |
98 | complement activation, classical pathway (GO:0006958) | 3.93105552 |
99 | plasma lipoprotein particle organization (GO:0071827) | 3.91470554 |
100 | protein activation cascade (GO:0072376) | 3.89010991 |
101 | cellular modified amino acid catabolic process (GO:0042219) | 3.87772724 |
102 | complement activation (GO:0006956) | 3.85664221 |
103 | negative regulation of protein activation cascade (GO:2000258) | 3.85042390 |
104 | cofactor catabolic process (GO:0051187) | 3.83434718 |
105 | aldehyde catabolic process (GO:0046185) | 3.81634192 |
106 | serine family amino acid biosynthetic process (GO:0009070) | 3.79219948 |
107 | positive regulation of coagulation (GO:0050820) | 3.77491374 |
108 | ethanol oxidation (GO:0006069) | 3.75779647 |
109 | cholesterol homeostasis (GO:0042632) | 3.75777162 |
110 | acute inflammatory response (GO:0002526) | 3.73815382 |
111 | phospholipid homeostasis (GO:0055091) | 3.73419033 |
112 | intestinal cholesterol absorption (GO:0030299) | 3.70501955 |
113 | sterol homeostasis (GO:0055092) | 3.69479355 |
114 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.68931108 |
115 | protein-lipid complex subunit organization (GO:0071825) | 3.67850272 |
116 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.67816672 |
117 | lipoprotein metabolic process (GO:0042157) | 3.65448227 |
118 | response to nitrosative stress (GO:0051409) | 3.64262778 |
119 | cytolysis (GO:0019835) | 3.61595417 |
120 | regulation of plasminogen activation (GO:0010755) | 3.58817392 |
121 | negative regulation of complement activation (GO:0045916) | 3.57755970 |
122 | regulation of lipoprotein particle clearance (GO:0010984) | 3.57081705 |
123 | flavonoid metabolic process (GO:0009812) | 3.56733784 |
124 | uronic acid metabolic process (GO:0006063) | 3.56584996 |
125 | glucuronate metabolic process (GO:0019585) | 3.56584996 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.21635615 |
2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.10495581 |
3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.10162727 |
4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.38202568 |
5 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.32965607 |
6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.29446697 |
7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.16360011 |
8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.19345236 |
9 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.11578067 |
10 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.03014508 |
11 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 12.0273828 |
12 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.98212346 |
13 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.97135050 |
14 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.61568303 |
15 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.60430026 |
16 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.46606728 |
17 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.45353147 |
18 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.40539300 |
19 | GATA1_22025678_ChIP-Seq_K562_Human | 1.31020069 |
20 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.28498069 |
21 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.27885824 |
22 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.18222132 |
23 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.16820944 |
24 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.13694248 |
25 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.10931759 |
26 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.06564735 |
27 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.00673238 |
28 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.00043497 |
29 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.95931226 |
30 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.92778365 |
31 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.89183966 |
32 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.86562583 |
33 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.82302220 |
34 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.81847248 |
35 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.81578748 |
36 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.79201340 |
37 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.79178016 |
38 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.79124093 |
39 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.78485014 |
40 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.76325956 |
41 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.73408595 |
42 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.73089129 |
43 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.73067696 |
44 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.72875934 |
45 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.72598850 |
46 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.72421348 |
47 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.72305515 |
48 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.71762184 |
49 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.70759374 |
50 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.69959815 |
51 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.68946718 |
52 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.67495605 |
53 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.67430153 |
54 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.67138563 |
55 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.66567080 |
56 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.66424910 |
57 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.66406872 |
58 | NFYA_21822215_ChIP-Seq_K562_Human | 0.66061699 |
59 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.65976266 |
60 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.65781181 |
61 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.65257767 |
62 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.65257767 |
63 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.63369990 |
64 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.62804778 |
65 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.62661448 |
66 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.62402877 |
67 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.61769345 |
68 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.61460818 |
69 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.60523084 |
70 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.59782943 |
71 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.59685072 |
72 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.59507368 |
73 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.59126519 |
74 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.58574946 |
75 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.57350611 |
76 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.57309345 |
77 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.55575491 |
78 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.54383023 |
79 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.53345377 |
80 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.53109945 |
81 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.52291554 |
82 | AR_20517297_ChIP-Seq_VCAP_Human | 0.51812443 |
83 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.51110240 |
84 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.50940102 |
85 | * EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.50266563 |
86 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.50255039 |
87 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.49956635 |
88 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.49675304 |
89 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.49397774 |
90 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.49341978 |
91 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.48915692 |
92 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.48254296 |
93 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.47309589 |
94 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.46750468 |
95 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.46527037 |
96 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.46488834 |
97 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.46369870 |
98 | * CTCF_27219007_Chip-Seq_Bcells_Human | 0.46313523 |
99 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.46285285 |
100 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.45483466 |
101 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.45277074 |
102 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.44216340 |
103 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.44146230 |
104 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.43011108 |
105 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.41974862 |
106 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.40914953 |
107 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.40783774 |
108 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.40763380 |
109 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.40456996 |
110 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.40334416 |
111 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.40025357 |
112 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.39703603 |
113 | GATA2_19941826_ChIP-Seq_K562_Human | 0.39182562 |
114 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.39036369 |
115 | GATA1_19941826_ChIP-Seq_K562_Human | 0.37519363 |
116 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.37315226 |
117 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.37301090 |
118 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.37141915 |
119 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.36893697 |
120 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.36431952 |
121 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.36314716 |
122 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.35982424 |
123 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.35648023 |
124 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.34951897 |
125 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.34872471 |
126 | * FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.33835966 |
127 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.33393777 |
128 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.32560467 |
129 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.31990311 |
130 | * NCOR_22424771_ChIP-Seq_293T_Human | 0.31981629 |
131 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.31598076 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 8.46479898 |
2 | MP0005360_urolithiasis | 7.41006476 |
3 | MP0005085_abnormal_gallbladder_physiolo | 6.38150864 |
4 | MP0005365_abnormal_bile_salt | 6.31952993 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.95300419 |
6 | MP0003806_abnormal_nucleotide_metabolis | 4.06123410 |
7 | MP0003252_abnormal_bile_duct | 3.75793045 |
8 | MP0010329_abnormal_lipoprotein_level | 3.60724993 |
9 | MP0009840_abnormal_foam_cell | 3.58347683 |
10 | MP0005083_abnormal_biliary_tract | 3.03160056 |
11 | MP0003191_abnormal_cellular_cholesterol | 2.84983388 |
12 | MP0003195_calcinosis | 2.75492188 |
13 | MP0005332_abnormal_amino_acid | 2.72775849 |
14 | MP0001666_abnormal_nutrient_absorption | 2.56324885 |
15 | MP0000609_abnormal_liver_physiology | 2.17867258 |
16 | MP0002118_abnormal_lipid_homeostasis | 2.09127562 |
17 | MP0002138_abnormal_hepatobiliary_system | 2.06694499 |
18 | MP0004019_abnormal_vitamin_homeostasis | 2.04730026 |
19 | MP0005319_abnormal_enzyme/_coenzyme | 1.79752924 |
20 | MP0003868_abnormal_feces_composition | 1.77324357 |
21 | MP0009697_abnormal_copulation | 1.67747869 |
22 | MP0001764_abnormal_homeostasis | 1.64290158 |
23 | MP0003011_delayed_dark_adaptation | 1.52894127 |
24 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.50952935 |
25 | MP0000604_amyloidosis | 1.25333286 |
26 | MP0003186_abnormal_redox_activity | 1.19159395 |
27 | MP0003656_abnormal_erythrocyte_physiolo | 1.18682767 |
28 | * MP0009643_abnormal_urine_homeostasis | 1.17263591 |
29 | MP0005451_abnormal_body_composition | 1.16920383 |
30 | MP0000598_abnormal_liver_morphology | 1.16711592 |
31 | MP0009764_decreased_sensitivity_to | 1.14541597 |
32 | MP0005647_abnormal_sex_gland | 1.11957730 |
33 | MP0003705_abnormal_hypodermis_morpholog | 1.11035056 |
34 | MP0009763_increased_sensitivity_to | 1.09264997 |
35 | MP0002254_reproductive_system_inflammat | 1.03905537 |
36 | MP0010368_abnormal_lymphatic_system | 0.97562219 |
37 | * MP0008469_abnormal_protein_level | 0.91878124 |
38 | * MP0005636_abnormal_mineral_homeostasis | 0.90805847 |
39 | * MP0009642_abnormal_blood_homeostasis | 0.88726669 |
40 | MP0005670_abnormal_white_adipose | 0.87751420 |
41 | MP0001915_intracranial_hemorrhage | 0.86333083 |
42 | MP0009765_abnormal_xenobiotic_induced | 0.80186580 |
43 | MP0005084_abnormal_gallbladder_morpholo | 0.80049173 |
44 | MP0005376_homeostasis/metabolism_phenot | 0.79505472 |
45 | MP0003690_abnormal_glial_cell | 0.79210685 |
46 | MP0005408_hypopigmentation | 0.78702356 |
47 | MP0009053_abnormal_anal_canal | 0.76641670 |
48 | MP0006036_abnormal_mitochondrial_physio | 0.75880908 |
49 | MP0005187_abnormal_penis_morphology | 0.74484402 |
50 | MP0002078_abnormal_glucose_homeostasis | 0.74463873 |
51 | MP0002282_abnormal_trachea_morphology | 0.73130036 |
52 | MP0002971_abnormal_brown_adipose | 0.73014263 |
53 | MP0005220_abnormal_exocrine_pancreas | 0.73009609 |
54 | MP0003329_amyloid_beta_deposits | 0.72606284 |
55 | MP0002876_abnormal_thyroid_physiology | 0.69438634 |
56 | MP0001661_extended_life_span | 0.68534810 |
57 | MP0003879_abnormal_hair_cell | 0.68481810 |
58 | MP0005464_abnormal_platelet_physiology | 0.68057232 |
59 | MP0005334_abnormal_fat_pad | 0.67573407 |
60 | MP0005058_abnormal_lysosome_morphology | 0.65046826 |
61 | MP0000639_abnormal_adrenal_gland | 0.63152870 |
62 | MP0005535_abnormal_body_temperature | 0.60873464 |
63 | MP0004130_abnormal_muscle_cell | 0.60319038 |
64 | MP0001986_abnormal_taste_sensitivity | 0.60285056 |
65 | MP0005266_abnormal_metabolism | 0.57923296 |
66 | MP0001756_abnormal_urination | 0.57101575 |
67 | MP0005448_abnormal_energy_balance | 0.52751017 |
68 | MP0002249_abnormal_larynx_morphology | 0.51963460 |
69 | MP0005395_other_phenotype | 0.51546287 |
70 | MP0006035_abnormal_mitochondrial_morpho | 0.48275888 |
71 | MP0004272_abnormal_basement_membrane | 0.48113234 |
72 | MP0008873_increased_physiological_sensi | 0.47641936 |
73 | MP0003436_decreased_susceptibility_to | 0.46902518 |
74 | MP0003724_increased_susceptibility_to | 0.46862992 |
75 | MP0003638_abnormal_response/metabolism_ | 0.46472116 |
76 | MP0008874_decreased_physiological_sensi | 0.45175530 |
77 | MP0003075_altered_response_to | 0.44258376 |
78 | MP0003718_maternal_effect | 0.42170699 |
79 | MP0009785_altered_susceptibility_to | 0.41843066 |
80 | MP0002822_catalepsy | 0.41763557 |
81 | MP0002928_abnormal_bile_duct | 0.41507235 |
82 | MP0005166_decreased_susceptibility_to | 0.41414914 |
83 | * MP0002136_abnormal_kidney_physiology | 0.41222227 |
84 | MP0000579_abnormal_nail_morphology | 0.41192576 |
85 | MP0003953_abnormal_hormone_level | 0.38539065 |
86 | MP0004883_abnormal_blood_vessel | 0.38153331 |
87 | MP0001881_abnormal_mammary_gland | 0.37089573 |
88 | MP0005666_abnormal_adipose_tissue | 0.37046168 |
89 | MP0000467_abnormal_esophagus_morphology | 0.36657615 |
90 | MP0005248_abnormal_Harderian_gland | 0.35916513 |
91 | MP0000249_abnormal_blood_vessel | 0.35767987 |
92 | MP0009384_cardiac_valve_regurgitation | 0.34533034 |
93 | MP0009115_abnormal_fat_cell | 0.34047353 |
94 | MP0005164_abnormal_response_to | 0.33532895 |
95 | MP0000566_synostosis | 0.33406110 |
96 | MP0001243_abnormal_dermal_layer | 0.32447155 |
97 | MP0002168_other_aberrant_phenotype | 0.32291072 |
98 | MP0008872_abnormal_physiological_respon | 0.31875110 |
99 | MP0001845_abnormal_inflammatory_respons | 0.31205332 |
100 | MP0005023_abnormal_wound_healing | 0.30875289 |
101 | MP0002837_dystrophic_cardiac_calcinosis | 0.30850438 |
102 | MP0002796_impaired_skin_barrier | 0.29782954 |
103 | MP0002970_abnormal_white_adipose | 0.29661629 |
104 | MP0004782_abnormal_surfactant_physiolog | 0.29583223 |
105 | MP0009672_abnormal_birth_weight | 0.28944402 |
106 | MP0001853_heart_inflammation | 0.28535220 |
107 | MP0006082_CNS_inflammation | 0.28037149 |
108 | MP0002089_abnormal_postnatal_growth/wei | 0.26917111 |
109 | MP0003632_abnormal_nervous_system | 0.26650727 |
110 | MP0004381_abnormal_hair_follicle | 0.25940313 |
111 | MP0005167_abnormal_blood-brain_barrier | 0.24737024 |
112 | MP0002132_abnormal_respiratory_system | 0.24647486 |
113 | MP0000230_abnormal_systemic_arterial | 0.24272685 |
114 | MP0000920_abnormal_myelination | 0.23933735 |
115 | MP0002128_abnormal_blood_circulation | 0.23529265 |
116 | MP0001851_eye_inflammation | 0.22568789 |
117 | MP0002090_abnormal_vision | 0.20584542 |
118 | MP0003941_abnormal_skin_development | 0.19430952 |
119 | MP0002332_abnormal_exercise_endurance | 0.19327192 |
120 | MP0002295_abnormal_pulmonary_circulatio | 0.18596501 |
121 | MP0005197_abnormal_uvea_morphology | 0.17538895 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Deep venous thrombosis (HP:0002625) | 7.56040938 |
2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.17170218 |
3 | Intrahepatic cholestasis (HP:0001406) | 7.08893642 |
4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.85375771 |
5 | Prolonged partial thromboplastin time (HP:0003645) | 6.81672046 |
6 | Hypobetalipoproteinemia (HP:0003563) | 6.51288945 |
7 | Xanthomatosis (HP:0000991) | 6.29392864 |
8 | Complement deficiency (HP:0004431) | 5.75439007 |
9 | Hyperlipoproteinemia (HP:0010980) | 5.60307906 |
10 | Joint hemorrhage (HP:0005261) | 5.02644381 |
11 | Abnormality of the common coagulation pathway (HP:0010990) | 4.93054062 |
12 | Hypolipoproteinemia (HP:0010981) | 4.92960344 |
13 | Hyperammonemia (HP:0001987) | 4.51532766 |
14 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.50660908 |
15 | Epidermoid cyst (HP:0200040) | 4.46057757 |
16 | Hypoalphalipoproteinemia (HP:0003233) | 4.33525859 |
17 | Abnormality of methionine metabolism (HP:0010901) | 4.23102406 |
18 | Abnormality of complement system (HP:0005339) | 4.20406045 |
19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.14457146 |
20 | Fat malabsorption (HP:0002630) | 4.13066195 |
21 | Ketosis (HP:0001946) | 4.12059859 |
22 | Hyperglycinemia (HP:0002154) | 4.11731389 |
23 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.04646581 |
24 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.03175123 |
25 | Hypoglycemic coma (HP:0001325) | 3.94250735 |
26 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.93248269 |
27 | Abnormality of the intrinsic pathway (HP:0010989) | 3.86203677 |
28 | Spontaneous abortion (HP:0005268) | 3.82853311 |
29 | Hypercholesterolemia (HP:0003124) | 3.69905748 |
30 | Conjugated hyperbilirubinemia (HP:0002908) | 3.63245693 |
31 | Abnormality of glycine metabolism (HP:0010895) | 3.59034533 |
32 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.59034533 |
33 | Hyperglycinuria (HP:0003108) | 3.58867218 |
34 | Hyperbilirubinemia (HP:0002904) | 3.27461281 |
35 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.16641136 |
36 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.11660929 |
37 | Steatorrhea (HP:0002570) | 3.10459616 |
38 | Abnormality of nucleobase metabolism (HP:0010932) | 3.06393648 |
39 | Ketoacidosis (HP:0001993) | 2.96588767 |
40 | Myocardial infarction (HP:0001658) | 2.92290436 |
41 | Hypochromic microcytic anemia (HP:0004840) | 2.90578819 |
42 | Systemic lupus erythematosus (HP:0002725) | 2.90567940 |
43 | Abnormality of serum amino acid levels (HP:0003112) | 2.88745046 |
44 | Hepatocellular carcinoma (HP:0001402) | 2.84312934 |
45 | Amyloidosis (HP:0011034) | 2.81776757 |
46 | Glomerulonephritis (HP:0000099) | 2.80863444 |
47 | Delayed CNS myelination (HP:0002188) | 2.79682285 |
48 | Skin nodule (HP:0200036) | 2.76419393 |
49 | Gingival bleeding (HP:0000225) | 2.75782891 |
50 | Osteomalacia (HP:0002749) | 2.75589704 |
51 | Hypoglycemic seizures (HP:0002173) | 2.70443166 |
52 | Abnormality of purine metabolism (HP:0004352) | 2.62966337 |
53 | Vascular calcification (HP:0004934) | 2.59753364 |
54 | Metabolic acidosis (HP:0001942) | 2.59595551 |
55 | Lethargy (HP:0001254) | 2.55534373 |
56 | Acanthocytosis (HP:0001927) | 2.54594209 |
57 | Cholecystitis (HP:0001082) | 2.53121473 |
58 | Abnormal gallbladder physiology (HP:0012438) | 2.53121473 |
59 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.51575649 |
60 | Mitral stenosis (HP:0001718) | 2.50674703 |
61 | Abnormal gallbladder morphology (HP:0012437) | 2.44159013 |
62 | Cerebral edema (HP:0002181) | 2.43057003 |
63 | Spastic diplegia (HP:0001264) | 2.42179207 |
64 | Late onset (HP:0003584) | 2.40946062 |
65 | Cholelithiasis (HP:0001081) | 2.40213128 |
66 | Abnormality of iron homeostasis (HP:0011031) | 2.38998231 |
67 | Irritability (HP:0000737) | 2.35002411 |
68 | Purpura (HP:0000979) | 2.34415046 |
69 | Dicarboxylic aciduria (HP:0003215) | 2.33550857 |
70 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.33550857 |
71 | Fair hair (HP:0002286) | 2.32831423 |
72 | Thrombophlebitis (HP:0004418) | 2.32785410 |
73 | Neonatal onset (HP:0003623) | 2.32361752 |
74 | Cardiovascular calcification (HP:0011915) | 2.30566501 |
75 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.28302598 |
76 | Gout (HP:0001997) | 2.26342457 |
77 | Abnormal delivery (HP:0001787) | 2.26166753 |
78 | Menorrhagia (HP:0000132) | 2.25560568 |
79 | Neonatal hypoglycemia (HP:0001998) | 2.25363731 |
80 | Esophageal varix (HP:0002040) | 2.24574040 |
81 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.23393495 |
82 | Pulmonary embolism (HP:0002204) | 2.19172069 |
83 | Malnutrition (HP:0004395) | 2.11478560 |
84 | Reduced antithrombin III activity (HP:0001976) | 2.10403324 |
85 | Epistaxis (HP:0000421) | 2.07724094 |
86 | Retinal atrophy (HP:0001105) | 2.07540206 |
87 | Brushfield spots (HP:0001088) | 2.07396142 |
88 | Pancreatitis (HP:0001733) | 2.06899889 |
89 | Sensorimotor neuropathy (HP:0007141) | 2.05502127 |
90 | Increased serum ferritin (HP:0003281) | 2.02064064 |
91 | Nephritis (HP:0000123) | 2.01950751 |
92 | Elevated alkaline phosphatase (HP:0003155) | 2.01568825 |
93 | Poikilocytosis (HP:0004447) | 2.01206960 |
94 | Vomiting (HP:0002013) | 2.01059534 |
95 | Enlarged kidneys (HP:0000105) | 2.00632331 |
96 | Opisthotonus (HP:0002179) | 1.99194446 |
97 | Abnormality of the gallbladder (HP:0005264) | 1.97518793 |
98 | Glycosuria (HP:0003076) | 1.96856220 |
99 | Abnormality of urine glucose concentration (HP:0011016) | 1.96856220 |
100 | Hyperphosphaturia (HP:0003109) | 1.95520539 |
101 | Arthropathy (HP:0003040) | 1.94921749 |
102 | Hemorrhage of the eye (HP:0011885) | 1.94006960 |
103 | Abnormality of the Achilles tendon (HP:0005109) | 1.89111068 |
104 | Rickets (HP:0002748) | 1.88152535 |
105 | Hyperglycemia (HP:0003074) | 1.87602344 |
106 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.87179024 |
107 | Abnormality of vitamin metabolism (HP:0100508) | 1.87059715 |
108 | Generalized aminoaciduria (HP:0002909) | 1.82264803 |
109 | Hypophosphatemic rickets (HP:0004912) | 1.81056926 |
110 | Abnormal cartilage morphology (HP:0002763) | 1.79932344 |
111 | Alkalosis (HP:0001948) | 1.78863954 |
112 | Symptomatic seizures (HP:0011145) | 1.74651708 |
113 | Elevated hepatic transaminases (HP:0002910) | 1.73739410 |
114 | Joint swelling (HP:0001386) | 1.73205244 |
115 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.73076762 |
116 | Status epilepticus (HP:0002133) | 1.71245913 |
117 | Reticulocytosis (HP:0001923) | 1.67272077 |
118 | Hypertriglyceridemia (HP:0002155) | 1.67055344 |
119 | Gangrene (HP:0100758) | 1.64612898 |
120 | Cerebral palsy (HP:0100021) | 1.64260357 |
121 | Generalized hypopigmentation of hair (HP:0011358) | 1.57966363 |
122 | Atrioventricular block (HP:0001678) | 1.56935006 |
123 | Abnormal urine phosphate concentration (HP:0012599) | 1.56811136 |
124 | Increased serum pyruvate (HP:0003542) | 1.53598389 |
125 | Bifid scrotum (HP:0000048) | 1.52169574 |
126 | Increased mean platelet volume (HP:0011877) | 1.49725151 |
127 | Abnormal biliary tract physiology (HP:0012439) | 1.48452808 |
128 | Bile duct proliferation (HP:0001408) | 1.48452808 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 6.90317276 |
2 | ERN1 | 4.87867308 |
3 | PDK2 | 4.81743041 |
4 | FGFR4 | 4.68468647 |
5 | SIK1 | 4.23902379 |
6 | TAOK3 | 3.42708694 |
7 | ERBB4 | 3.16105287 |
8 | INSRR | 2.79729923 |
9 | DAPK2 | 2.30477945 |
10 | MAP2K4 | 2.28607258 |
11 | MST1R | 2.12742017 |
12 | PIK3CG | 2.06932870 |
13 | NTRK3 | 1.95362127 |
14 | MAPK11 | 1.91869184 |
15 | TRIB3 | 1.82472405 |
16 | PKN2 | 1.77353747 |
17 | TYK2 | 1.69292828 |
18 | LMTK2 | 1.62904932 |
19 | FLT3 | 1.60856542 |
20 | PTK6 | 1.57858838 |
21 | LATS1 | 1.48264525 |
22 | TESK2 | 1.47814909 |
23 | NEK9 | 1.44740101 |
24 | ABL2 | 1.44285188 |
25 | MAP3K12 | 1.37655972 |
26 | PRPF4B | 1.35020312 |
27 | FRK | 1.34427555 |
28 | JAK2 | 1.26114511 |
29 | KDR | 1.25080533 |
30 | MAP3K2 | 1.24396407 |
31 | EPHB1 | 1.19749178 |
32 | FGFR2 | 1.18770620 |
33 | EPHA3 | 1.14639265 |
34 | TBK1 | 1.12946567 |
35 | ERBB2 | 1.12892972 |
36 | FER | 1.12800585 |
37 | PBK | 1.12561838 |
38 | NLK | 1.10558905 |
39 | GRK6 | 1.09859033 |
40 | MAP3K7 | 1.08732703 |
41 | JAK1 | 1.05295618 |
42 | PRKAA2 | 1.05209617 |
43 | SCYL2 | 1.00250663 |
44 | MAPK4 | 0.96537960 |
45 | ACVR1B | 0.95459272 |
46 | MAP3K14 | 0.95027301 |
47 | MAP2K3 | 0.94360884 |
48 | MAP3K11 | 0.91323255 |
49 | PRKG1 | 0.89156228 |
50 | CAMK2G | 0.88964474 |
51 | MET | 0.88738486 |
52 | PINK1 | 0.88416108 |
53 | PRKCZ | 0.86429451 |
54 | CASK | 0.85097061 |
55 | MAPK12 | 0.84727514 |
56 | MAP3K3 | 0.84493834 |
57 | AKT3 | 0.83364839 |
58 | WNK3 | 0.82988452 |
59 | MYLK | 0.82790804 |
60 | TNK2 | 0.82020799 |
61 | PRKACG | 0.81635815 |
62 | CAMK1D | 0.80752424 |
63 | RIPK1 | 0.80302084 |
64 | MUSK | 0.78836137 |
65 | MAP3K10 | 0.77759253 |
66 | DYRK1B | 0.74932198 |
67 | PRKACA | 0.73720058 |
68 | CSNK1D | 0.73404557 |
69 | CDK6 | 0.70800331 |
70 | TIE1 | 0.66045188 |
71 | MAPK15 | 0.66026909 |
72 | CSK | 0.65564167 |
73 | PIK3CA | 0.65516608 |
74 | MAP2K6 | 0.64713727 |
75 | GSK3A | 0.64340524 |
76 | PDGFRA | 0.64029318 |
77 | STK38L | 0.63037257 |
78 | PRKCB | 0.61875905 |
79 | MAP2K1 | 0.61830449 |
80 | IKBKE | 0.59056828 |
81 | CSF1R | 0.57060395 |
82 | FGFR3 | 0.56961831 |
83 | EPHA4 | 0.55580628 |
84 | PTK2 | 0.55059389 |
85 | PRKAA1 | 0.54408943 |
86 | MAPK7 | 0.53326177 |
87 | CSNK1E | 0.53018079 |
88 | TGFBR2 | 0.52841098 |
89 | SGK3 | 0.52006620 |
90 | PRKG2 | 0.51426305 |
91 | PDPK1 | 0.51090786 |
92 | PKN1 | 0.50588601 |
93 | ZAP70 | 0.50056395 |
94 | IGF1R | 0.45418086 |
95 | PRKCQ | 0.45381382 |
96 | PRKCG | 0.44972368 |
97 | CSNK2A1 | 0.43824055 |
98 | MAP3K13 | 0.43190854 |
99 | RPS6KA3 | 0.41776302 |
100 | ICK | 0.41638058 |
101 | SRC | 0.41361505 |
102 | CSNK1G1 | 0.41325242 |
103 | CAMK4 | 0.40706545 |
104 | CSNK1A1 | 0.40617849 |
105 | MAP3K5 | 0.40398307 |
106 | EGFR | 0.40290396 |
107 | MTOR | 0.39264227 |
108 | RET | 0.37919350 |
109 | CSNK2A2 | 0.37773409 |
110 | STK38 | 0.36933006 |
111 | TAOK2 | 0.36694140 |
112 | BLK | 0.36382111 |
113 | IRAK3 | 0.35421119 |
114 | KSR2 | 0.35282981 |
115 | SGK1 | 0.35116292 |
116 | SGK2 | 0.34759118 |
117 | CDK4 | 0.34430798 |
118 | MAP3K6 | 0.34104932 |
119 | NEK6 | 0.32786981 |
120 | GRK1 | 0.32502806 |
121 | MAP3K1 | 0.31293262 |
122 | PDK1 | 0.30983440 |
123 | PAK3 | 0.30038297 |
124 | CAMK1G | 0.29255446 |
125 | PRKACB | 0.28329675 |
126 | PRKCA | 0.28053296 |
127 | BMX | 0.27885959 |
128 | EPHA2 | 0.27227654 |
129 | SGK223 | 0.25888180 |
130 | SGK494 | 0.25888180 |
131 | LATS2 | 0.25815102 |
132 | CSNK1G2 | 0.23431326 |
133 | CSNK1G3 | 0.22989536 |
134 | IRAK1 | 0.22547577 |
135 | MAPK3 | 0.20459576 |
136 | ABL1 | 0.19240816 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.53281549 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.58956714 |
3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.49997403 |
4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.26675173 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.19112107 |
6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.04847724 |
7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.65412847 |
8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.61116334 |
9 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.56217760 |
10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.52864479 |
11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.36658260 |
12 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.29356885 |
13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.27169269 |
14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.18112197 |
15 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.08545066 |
16 | Peroxisome_Homo sapiens_hsa04146 | 2.04773323 |
17 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.03565975 |
18 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.03515751 |
19 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.96597208 |
20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.87259034 |
21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.86183169 |
22 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.83574872 |
23 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.80409068 |
24 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.75192959 |
25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.72373472 |
26 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.72286903 |
27 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.70642392 |
28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.62876027 |
29 | Retinol metabolism_Homo sapiens_hsa00830 | 1.61543141 |
30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.59019683 |
31 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.58504748 |
32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.55683591 |
33 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.50830847 |
34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.48884080 |
35 | Bile secretion_Homo sapiens_hsa04976 | 1.47946446 |
36 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.46152345 |
37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.43060052 |
38 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.36469081 |
39 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.31600710 |
40 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.29612991 |
41 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.28033725 |
42 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.27303143 |
43 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.26513561 |
44 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.24747943 |
45 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.22513284 |
46 | ABC transporters_Homo sapiens_hsa02010 | 1.21727279 |
47 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.21263292 |
48 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.13008323 |
49 | Carbon metabolism_Homo sapiens_hsa01200 | 1.12260160 |
50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.02758744 |
51 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.00277108 |
52 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.97966237 |
53 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.97642899 |
54 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.95601063 |
55 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.95313032 |
56 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.91130694 |
57 | Sulfur relay system_Homo sapiens_hsa04122 | 0.91084772 |
58 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.83352977 |
59 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.80526975 |
60 | Lysine degradation_Homo sapiens_hsa00310 | 0.75401502 |
61 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.74242071 |
62 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.73144837 |
63 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.69698038 |
64 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.63728244 |
65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.63197271 |
66 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.49898646 |
67 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.45902008 |
68 | Metabolic pathways_Homo sapiens_hsa01100 | 0.43942881 |
69 | Prion diseases_Homo sapiens_hsa05020 | 0.40536558 |
70 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.30506406 |
71 | Galactose metabolism_Homo sapiens_hsa00052 | 0.28139417 |
72 | Other glycan degradation_Homo sapiens_hsa00511 | 0.27276245 |
73 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.21846129 |
74 | Insulin resistance_Homo sapiens_hsa04931 | 0.21722371 |
75 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21528371 |
76 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.15600066 |
77 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.15272773 |
78 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.13718038 |
79 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.11573447 |
80 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01779902 |
81 | Mineral absorption_Homo sapiens_hsa04978 | 0.01253400 |
82 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2546418 |
83 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2523271 |
84 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2492365 |
85 | ECM-receptor interaction_Homo sapiens_hsa04512 | -0.2416238 |
86 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.2369003 |
87 | Circadian rhythm_Homo sapiens_hsa04710 | -0.2326764 |
88 | Amoebiasis_Homo sapiens_hsa05146 | -0.2215689 |
89 | Pertussis_Homo sapiens_hsa05133 | -0.2206944 |
90 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.2078371 |
91 | Bladder cancer_Homo sapiens_hsa05219 | -0.1829855 |
92 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1792821 |
93 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1773281 |
94 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1732375 |
95 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1688585 |
96 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1637894 |
97 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.1562156 |
98 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1561925 |
99 | Hepatitis C_Homo sapiens_hsa05160 | -0.1549093 |
100 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1544382 |
101 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1220728 |
102 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1145754 |
103 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1139064 |
104 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1103813 |
105 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1032708 |
106 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0960445 |
107 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0597840 |
108 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0450326 |
109 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0335350 |
110 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.0294463 |